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Background and purpose: The reduction of delay between onset and hospital arrival
and adequate pre-hospital care of persons with acute stroke are important for improv-
ing the chances of a favourable outcome. The objective is to recommend evidence-based
practices for the management of patients with suspected stroke in the pre-hospital set-
ting.
Methods: The GRADE (Grading of Recommendations Assessment, Development
and Evaluation) methodology was used to deﬁne the key clinical questions. An
expert panel then reviewed the literature, established the quality of the evidence,
and made recommendations.
Results: Despite very low quality of evidence educational campaigns to increase the
awareness of immediately calling emergency medical services are strongly recom-
mended. Moderate quality evidence was found to support strong recommendations
for the training of emergency medical personnel in recognizing the symptoms of a
stroke and in implementation of a pre-hospital ‘code stroke’ including highest prior-
ity dispatch, pre-hospital notiﬁcation and rapid transfer to the closest ‘stroke-ready’
centre. Insuﬃcient evidence was found to recommend a pre-hospital stroke scale to
predict large vessel occlusion. Despite the very low quality of evidence, restoring nor-
moxia in patients with hypoxia is recommended, and blood pressure lowering drugs
and treating hyperglycaemia with insulin should be avoided. There is insuﬃcient evi-
dence to recommend the routine use of mobile stroke units delivering intravenous
thrombolysis at the scene. Because only feasibility studies have been reported, no rec-
ommendations can be provided for pre-hospital telemedicine during ambulance
transport.
Conclusions: These guidelines inform on the contemporary approach to patients
with suspected stroke in the pre-hospital setting. Further studies, preferably ran-
domized controlled trials, are required to examine the impact of particular inter-
ventions on quality parameters and outcome.
*Correspondence: A. Kobayashi, Interventional Stroke and Cerebrovascular Disease Treatment Centre, Second Department of Neurology, Institute of
Psychiatry and Neurology, ul. Sobieskiego 9, 02-957 Warsaw, Poland (tel.: +48 222182243; fax: +48 222182319; e-mail: akobayas@ipin.edu.pl)
This is a Continuing Medical Education article, and can be found with corresponding questions on the EAN website, LEARN section https://
www.ean.org/CME.2714.0.html. Certiﬁcates for correctly answered questions will be issued by EAN directly, you simply have to be logged-in.
With positive results, EAN recommends accreditation of 1 hour of CME, which may be claimed with the national body in charge of CME
accreditation. This paper is being simultaneously published in European Journal of Neurology and Multiple Sclerosis Journal.
© 2017 EAN 425




























Stroke is a leading cause of disability in adults and a
major cause of death. Speciﬁc therapies for acute
stroke are most eﬀective when initiated soon after
symptom onset. This requires rapid clinical assessment
and brain imaging.
Intravenous thrombolysis with recombinant tissue
plasminogen activator is eﬀective in acute ischaemic
stroke up to 4.5 h after symptom onset, and recent trials
have shown signiﬁcant additional beneﬁts of thrombec-
tomy in patients with large vessel occlusion [1,2]. As
time is critical for improving outcome, appropriate pre-
hospital assessment and management of persons sus-
pected of acute stroke are important for reducing delays
for revascularization therapies, and in the meantime
limiting secondary brain damage during transport.
The purpose of this clinical guideline is to develop
recommendations for the management of persons with
suspected acute stroke from the scene to the hospital.
Methodology
A working group consisting of experts in acute stroke
medicine and neurology, an expert on guideline
methodology and a representative of the European
patient organization Stroke Alliance for Europe was
proposed by the Stroke Scientist Panel of the former
European Federation of Neurological Sciences
(EFNS), the European Stroke Organization Guidelines
Committee and the Subcommittee for Cerebrovascular
Diseases of the former European Neurological Society.
The guideline was developed in concordance with
the Grading of Recommendations Assessment, Devel-
opment and Evaluation (GRADE) methodology [3].
The work of this task force was set up during a stage
when the recent standard operating procedures for
writing guideline documents of the European Stroke
Organization and European Academy of Neurology
(EAN) were not yet eﬀective [4,5].
During a ﬁrst meeting, the members of the working
group established a consensus on 14 speciﬁc PICO
(patient, intervention, comparator, outcome) ques-
tions. For each PICO question two members were
assigned to perform a literature search using relevant
MeSH terms. A search of MEDLINE, Embase and
the Cochrane Library was performed up to March
2016. Language restrictions were not applied. Confer-
ence reports and case reports were excluded.
All selected articles were cross-referenced to make
certain that no relevant studies were excluded. Refer-
ences cited in the selected articles were checked for fur-
ther relevant articles not identiﬁed by the electronic
searches. Two reviewers read all identiﬁed papers and
disagreements were resolved through discussion. When
a recent systematic review was available to answer a
PICO question, only the literature after publication of
the systematic review was further assessed. During a
second meeting of the working group, the quality of
evidence was derived, and strength of recommendation
was decided by consensus. Quality of evidence was
graded as high, moderate, low or very low [3]. A sum-
mary of ﬁndings table to obtain an overall eﬀect esti-
mate is only presented when homogeneous randomized
controlled trials (RCTs) were available. For a number
of PICO questions, an ‘additional information’ section
is added just after the recommendation section.
Results
The recommendations for each PICO question are
summarized.
Rapid recognition of stroke
PICO 1. In people with suspected acute stroke, do edu-
cational interventions aimed at the general public
increase the likelihood of the emergency medical ser-
vices (EMS) being called immediately?
Randomized controlled trials investigating the eﬀect of
educational interventions on the interval between onset
of symptoms and EMS call were not found. A related
but indirect outcome, reduction in pre-hospital delay,
was recently assessed in a systematic review [6], includ-
ing 13 studies. Only one, the Berlin Acute Stroke Study,
was a cluster RCT [7]. The educational intervention
consisted of a letter indicating stroke symptoms and
emphasizing the need to call EMS immediately, accom-
panied by a sticker with main stroke symptoms and the
telephone number of the EMS. A total of 75 720 house-
holds received the intervention. The intervention was
found to be eﬀective in reducing pre-hospital delays in
women but not in men. However, the study had several
limitations, including a limited precision of time assess-
ments. The other studies were before and after studies
or observational studies. Ten studies reported a statisti-
cally signiﬁcant reduction in pre-hospital delay follow-
ing the educational intervention. Heterogeneity and
methodological weaknesses limit a proper meta-analy-
sis and generalizability of the observed eﬀects. The
working group decided to give a strong recommenda-
tion despite the very low quality of evidence, because
the possible beneﬁt of early recognition of stroke symp-
toms by the general population and of immediate EMS
call clearly outweighs any possible harm. Sustained
campaigns should remain the cornerstone to educate
the general population in recognizing stroke symptoms
and the need to call EMS immediately (Table 1).
© 2017 EAN
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Recommendation
Educational campaigns are recommended to increase
the awareness of immediately calling EMS for people
with suspected stroke.
(strong; very low quality of evidence)
PICO 2. For EMS technicians and paramedics, are
simple pre-hospital stroke scales useful to identify
potential stroke patients?
A recent systematic review was identiﬁed examining
the accuracy of recognizing pre-hospital stroke
patients using the QUADAS-2 tool. The following
simple stroke scales were included: the Face Arm
Speech Test (FAST), Cincinnati Pre-hospital Stroke
Scale (CPSS), Los Angeles Pre-hospital Stroke Screen
(LAPSS), Melbourne Ambulance Stroke Screen
(MASS), Medic Pre-hospital Assessment for Code
Stroke (Med PACS), Ontario Pre-hospital Stroke
Screening Tool (OPSS) and Recognition of Stroke in
the Emergency Room (ROSIER) [6]. All of the above
studies were observational studies and excluded those
in which physicians were involved in pre-hospital
application of the stroke scale. Pre-hospital stroke
scales varied in their accuracy and globally missed up
to 30% of acute strokes in the ﬁeld. All stroke scales
had a high sensitivity, ranging from 74%–97%. Speci-
ﬁcity of the comparable FAST (13%) and CPSS
(24%–79%) was lower than scales including more
items, such as LAPSS (85%–97%), MASS (74%–
86%) and OPPS (86%), with the exception of Med
PACS (33%) and ROSIER (18%). Despite the low
quality of evidence a strong recommendation is issued
because the possible beneﬁt of identifying potential
stroke victims clearly outweighs any possible harm
and the associated resource use is minimal.
Recommendation
It is recommended that all EMS technicians and para-
medics are familiar with a simple pre-hospital stroke
scale to identify potential stroke patients. No speciﬁc
scale can be recommended.
(strong; low quality of evidence)
Additional information
Current simple pre-hospital stroke scales are not sensi-
tive for detecting posterior circulation stroke.
Table 1 Summary of recommendations
PICO Recommendation Quality of evidence
Strength of
recommendation
1 Educational campaigns to increase the awareness of immediately calling
EMS for people with suspected stroke are recommended
Very low Strong
2 It is recommended that all EMS technicians and paramedics are familiar
with a simple pre-hospital stroke scale to identify potential stroke patients.
No speciﬁc scale can be recommended
Low Strong
3 There is insuﬃcient evidence to recommend a pre-hospital stroke scale to
predict large vessel occlusion
4 In patients with SaO2 levels <95% the administration of O2 titrated to
maintain normoxia is recommended. Routine use of O2 is not recommended
Very low Weak
5 Pre-hospital treatment of high blood pressure in people suspected of
acute stroke is not recommended
Very low Weak
6 Because of safety concerns pre-hospital administration of insulin in persons
with suspected stroke and hyperglycaemia is not recommended
Very low Weak
7 In the absence of clinical studies no recommendations can be made on
pre-hospital interventions for lowering elevated body temperature
8 It is recommended that all EMS implement a ‘code stroke’ protocol,
including highest priority dispatch, pre-hospital notiﬁcation and rapid
transfer to the closest ‘stroke-ready’ centre
Moderate Strong
9 No recommendation on the additional value of pre-hospital
telemedicine can be made
10 The routine use of mobile emergency stroke units is not recommended
because there is insuﬃcient evidence that they lead to a better functional outcome
Low Weak
11 No recommendation can be made on the pre-hospital use of POC laboratory
analysis of blood count and INR
12 No recommendation can be made on the use of currently available
biomarkers in persons with a suspected stroke
13 Air medical transport is not suggested outside of settings where a pragmatic
decision has been taken that geographical conditions favour air transport
Weak Very low
14 The use of any neuroprotective intervention is not recommended High Strong
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PICO 3. For EMS technicians and paramedics, are
pre-hospital stroke scales useful for predicting large ves-
sel occlusion?
A retrospective analysis of two databases including
119 patients reported that a hospital score ≥4 on the
Los Angeles Motor Scale predicted the presence of
large artery anterior circulation occlusion with high
sensitivity (81%) and speciﬁcity (89%) [7]. However,
this has not been prospectively validated. The Rapid
Arterial Occlusion Evaluation (RACE) scale was vali-
dated prospectively in the pre-hospital setting by
trained EMS technicians for 357 consecutive patients
in a single comprehensive stroke centre study. Large
vessel occlusion was diagnosed by transcranial duplex,
computed tomography (CT) angiography or magnetic
resonance angiography. A RACE scale score ≥5 had a
sensitivity of 85%, speciﬁcity of 68%, positive predic-
tive value of 42% and negative predictive value of
94% for detecting large artery anterior circulation
occlusion [8]. There is insuﬃcient evidence that these
stroke scales could be useful instruments for selecting
stroke patients for direct transport to comprehensive
stroke centres.
Recommendation
There is insuﬃcient evidence to recommend a pre-hos-
pital stroke scale to predict large vessel occlusion.
Rapid stabilization of vital parameters
PICO 4. In people with suspected acute stroke who are
hypoxic, does pre-hospital O2 administration compared
to no O2 administration improve outcome?
Studies investigating in-hospital routine O2 therapy
started <24 h after stroke onset (2 or 3 l/min for 24–
72 h), although showing slight improvement in neu-
rological status 7 days after stroke onset, failed to
show a beneﬁt in terms of long-term survival and
independence [9–11]. No RCT has compared O2
administration versus no O2 administration in per-
sons suspected of acute stroke in the pre-hospital set-
ting. Hypoxia should be avoided because it may
amplify ischaemic brain damage and worsen outcome
[12]. Although there are no supportive RCTs, the
working group decided to follow the guidelines pub-
lished by the British Thoracic Society advocating
titrated O2 therapy [13].
Recommendation
In patients with SaO2 levels <95% the administration
of O2 titrated to maintain normoxia is suggested.
Routine use of O2 is not recommended.
(weak; very low quality of evidence)
PICO 5. In people with suspected acute stroke, does pre-
hospital high blood pressure reduction compared to no
intervention on blood pressure improve outcome?
Both hypertension and marked hypotension are associ-
ated with poor outcome after stroke [14], and there is
considerable clinical uncertainty as to the optimal man-
agement of blood pressure acutely after stroke. There
are two small single centre feasibility RCTs in pre-hos-
pital acute stroke patients who were hypertensive (sys-
tolic blood pressure ≥140 mmHg or >160 mmHg)
assessing the safety and outcome of antihypertensive
therapy. The Rapid Intervention with Glyceryl Trini-
trate in Hypertensive Stroke Trial and the Paramedic
Initiated Lisinopril for Acute Stroke Treatment Trial
showed that it was feasible to perform an ambulance-
based paramedic-delivered trial of blood pressure low-
ering in patients with acute stroke (<4 h of stroke
onset) [15,16]. Both trials selected the immediate blood
pressure lowering eﬀect as the primary outcome. Due
to the small size of the studies (55 patients recruited in
total) no conclusions on safety, eﬃcacy and outcome
could be drawn from this study. Even for systolic blood
pressure ≥185 mmHg, which may prolong door to nee-
dle time, urgent pre-hospital antihypertensive treatment
by paramedics holds a risk for sudden drops of the
blood pressure; therefore treatment of high blood pres-
sure in the pre-hospital phase should be avoided.
Recommendation
Pre-hospital treatment of high blood pressure in peo-
ple suspected of acute stroke is not recommended.
(weak; very low quality of evidence)
PICO 6. In people with suspected acute stroke, does
pre-hospital treatment of hyperglycaemia with insulin
compared to no treatment improve outcome?
Blood glucose should be measured in every patient
with suspected stroke because symptoms of hypogly-
caemia can mimic those of a stroke. Hypoglycaemia
(<60 mg/dl or <3.3 mmol/l) needs to be treated with
glucose 20%–40% in 25–50 ml infusion [17].
People with hyperglycaemia concomitant with large
vessel acute ischaemic stroke have greater mortality,
stroke severity and functional impairment compared
with those with normoglycaemia. However, this has not
been found in patients with a lacunar stroke [18,19].
Only one small feasibility study dealing with lowering
glucose in acute stroke patients in the pre-hospital
setting was identiﬁed [20]. In this study, patients with
stroke symptoms and plasma glucose >108 mg/dl or
6.0 mmol/l were randomized during the pre-hospital
phase to receive either a single subcutaneous dose of
short-acting insulin (n = 11) or a continuous intravenous
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insulin infusion (n = 12) at a rate adjusted by glucose
levels measured every 10 min and targeted to plasma
glucose 4.5–6.0 mmol/l. Plasma glucose levels were sig-
niﬁcantly decreased with no serious adverse events in
the intravenously treated group in comparison to a
non-randomized control group (n = 38). The subcuta-
neous insulin administration did not achieve signiﬁcant
lowering of plasma glucose.
A systematic review showed that the in-hospital
administration of intravenous insulin with the objec-
tive of maintaining serum glucose within a speciﬁc
range in the ﬁrst hours of acute ischaemic stroke does
not provide beneﬁt in terms of functional outcome,
death or improvement in ﬁnal neurological deﬁcit,
and signiﬁcantly increased the number of hypogly-
caemic episodes [21]. Speciﬁcally, the people whose
glucose levels were maintained within a tighter range
with intravenous insulin experienced a greater risk of
symptomatic and asymptomatic hypoglycaemia than
the people in the control group. The situation may
therefore be even more risky in the pre-hospital phase.
Recommendation
Because of safety concerns pre-hospital administration
of insulin in persons with suspected stroke and hyper-
glycaemia is not recommended.
(weak; very low quality of evidence)
PICO 7. In people with suspected acute stroke, does
pre-hospital lowering of elevated body temperature com-
pared to no intervention on body temperature improve
outcome?
Data on 5305 patients from the Virtual International
Stroke Trials Archive data set showed that delayed
hyperthermia was more strongly associated with poor
outcome than elevated body temperature seen in the
hours after stroke [22]. A prospective study of 725
patients also found that initial elevated body tempera-
ture in hyperacute ischaemic stroke was not associated
with worse outcome, but a rise in body temperature
in severe strokes was related to poor outcome. It was
concluded that elevated body temperature within 6 h
of stroke onset had no prognostic inﬂuence on stroke
outcome at 3 months [23].
Antipyretic drugs and cooling methods can lower
body temperature in stroke patients. However, no clin-
ical studies have investigated pre-hospital treatment of
elevated body temperature in acute stroke patients.
Recommendation
In the absence of clinical studies no recommendations
can be made on pre-hospital interventions for lower-
ing elevated body temperature.
Rapid care by a dedicated stroke team
PICO 8. In patients with suspected acute stroke, does
implementation of pre-hospital ‘code stroke’ protocols
compared to no implementation of such protocols reduce
onset to admission time, door to needle time and fre-
quency of thrombolysis?
The search revealed 43 citations, of which nine stud-
ies, including one RCT, were considered relevant. The
RCT, performed in the Stockholm area, compared the
eﬀect of upgrading the priority level at the Emergency
Medical Communication Centre (EMCC) from the
standard level 2 (ambulance arrival at scene within
30 min unless no priority 1 alarms required that
ambulance) to level 1 (immediate ambulance response)
[24]. In the group randomized to level 1 there was a
signiﬁcantly shorter delay (13 min) from EMCC call
to arrival at the hospital (P < 0.001) and a signiﬁcant
increase in thrombolysis frequency (24% vs. 10%;
P < 0.001). The door to needle time was not signiﬁ-
cantly diﬀerent as eligible patients from the control
group were also prioritized at the emergency
department.
Several observational studies have reported that
pre-hospital notiﬁcation of the receiving hospital with-
out or with prioritized transport to designated hospi-
tals with stroke expertise (bypassing the nearest
hospitals) led to signiﬁcantly shorter door to needle
time or door to brain imaging time [25–32] and higher
rates of intravenous thrombolysis [25,26,28–31]. Most
studies compared ﬁndings either with ﬁndings from a
historical control group (six) or with ﬁndings from a
parallel observation of patients for whom no pre-noti-
ﬁcation intervention was used (two). In most studies
improved pre-hospital management was also associ-
ated with improved in-hospital reorganization, indi-
cating that pre-hospital ‘code stroke’ and in-hospital
‘code stroke’ are a continuum aimed at shortening
onset to treatment time. A meta-analysis of these
observational studies is not feasible because of diﬀer-
ent study designs and methodological approaches, and
qualitative diﬀerences in regional EMS organization
where the studies were performed. However, all stud-
ies consistently show that implementing a pre-hospital
‘code stroke’ protocol including priority EMS dis-
patch, rapid transport to the closest ‘stroke ready’
centre (bypassing nearest hospitals that are not ‘stroke
ready’) and pre-arrival notiﬁcation to the receiving
hospital leads to faster times to treatment and higher
treatment rates.
Recommendation
It is recommended that all EMS implement a ‘code
stroke’ protocol, including highest priority dispatch,
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pre-hospital notiﬁcation and rapid transfer to the clos-
est ‘stroke-ready’ centre.
(strong; moderate quality of evidence)
PICO 9. In people with suspected stroke does pre-hospi-
tal telemedicine, compared to no telemedicine, improve
outcome?
Telemedicine with real-time bidirectional audiovideo
communication between the ambulance and a stroke
physician may enable early assessment of a patient with
suspected stroke and might thereby reduce in-hospital
delays to receive relevant treatment. Thirty-six papers
were identiﬁed. Pilot studies indicate that this approach
is feasible [33,34]. No RCTs were found on whether
pre-hospital telemedicine in acute stroke patients speeds
up door to treatment time and improves outcome. Only
one observational study compared door to imaging
time in patients who received pre-hospital telemedicine
(n = 16) versus controls (n = 42). No statistically signif-
icant diﬀerence was found between door to imaging
time in patients who received pre-hospital telemedicine:
median (interquartile range) 59.5 (67.5) min versus con-
trols 57.5 (80) min, P = 0.65 [33].
Recommendation
No recommendation on the additional value of pre-
hospital telemedicine can be made.
PICO 10. In patients with acute stroke, does the use of
mobile emergency stroke units, compared to no use of
such units, improve outcome?
Studies with mobile emergency stroke units, which are
specialized ambulances staﬀed by a neurologist/physi-
cian or nurse, paramedic/emergency medical techni-
cian and radiology technician, and equipped with a
CT scanner, point-of-care laboratory and telemedicine
connection were searched for. Thrombolysis was
administered at the scene in the mobile stroke unit.
The search revealed three relevant studies: two RCTs
[35,36] and one small observational study [37]. Studies
were unblinded and speciﬁc to the local setting.
Grading of the quality of evidence was based on the
two RCTs comparing mobile emergency stroke unit
intervention with hospital intervention (Appendix S1,
GRADE table). In the mobile emergency stroke unit
group, rate of thrombolysis was increased [odds ratio
(OR) 1.79; 95% conﬁdence interval (CI) 1.44–2.33], with
a median reduction in call to needle time of 24–34 min
and a median reduction in onset to needle time of 24–
81 min. No safety concerns have been raised. There was
no increase in symptomatic intracranial haemorrhage
(OR 0.59; 95% CI 0.25–1.38) in the mobile emergency
stroke unit group. However, there were insuﬃcient data
about functional outcome to determine eﬀectiveness.
Only one study investigated 7-day outcome [35]. There
was no signiﬁcant diﬀerence between the mobile emer-
gency stroke unit group and the control group in the
number of patients who were independently deﬁned as a
modiﬁed Rankin Scale score <3. In the large PHAN-
TOM-S trial [36], mean door to needle time in the control
group receiving usual hospital care was 42 min, which
could be further improved by reducing in-hospital delays.
Two studies provided arguments in support of the cost-
eﬀectiveness of mobile emergency stroke units [38,39].
Recommendation
The routine use of mobile emergency stroke units is
not recommended because there is insuﬃcient evi-
dence that they lead to better functional outcome.
(weak; low quality of evidence)
Additional comments
Although the inﬂuence of mobile emergency stroke units
on the outcome of patients with stroke is uncertain, they
can reduce onset to needle times for intravenous throm-
bolysis in patients with ischaemic stroke and can be an
option for certain regions where traditional ambulance
transport would result in signiﬁcant delays.
PICO 11. In persons with suspected acute stroke, does
the use of pre-hospital point-of-care (POC) laboratory
analysis of blood count and international normalized
ratio (INR), compared to no use of such means, speed
up door to needle time in ischaemic stroke or interven-
tions to prevent worsening of haemorrhagic stroke?
Determination of the platelet count and INR is impor-
tant in patients taking vitamin K antagonists, with
liver dysfunction, haemorrhagic diathesis or an unclear
medication history. Observational studies reported
that measuring these parameters by POC testing in the
emergency department, instead of awaiting central lab-
oratory results, reduced door to needle time [40,41].
No clinical trial has assessed whether pre-hospital
POC analyses of INR and blood count have an addi-
tional eﬀect in reducing door to needle time or improv-
ing management of haemorrhagic stroke.
Recommendation
No recommendation on the use of pre-hospital POC lab-
oratory analysis of blood count and INR can be made.
PICO 12. In persons with suspected acute stroke, can
biomarkers accurately diﬀerentiate between ischaemic
stroke, haemorrhagic stroke or a stroke mimic?
A comprehensive systematic review using QUADAS
criteria for assessing the quality of studies found that
© 2017 EAN
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no individual biomarker has adequate sensitivity and
speciﬁcity for a clinically useful diagnostic test [42]. A
number of studies have attempted a multi-marker
panel approach in order to improve sensitivity and
speciﬁcity. However, thus far none has been successful
in a clinical setting. None of these studies was per-
formed in a pre-hospital setting [42].
Recommendation
No recommendation can be made on the use of cur-
rently available biomarkers in persons with a sus-
pected stroke.
PICO 13. In persons suspected of acute stroke, does air
medical transport compared to ground transport
improve outcome?
The search revealed 88 citations, of which only one
observational study made an acceptable comparison
to ground transport. This retrospective examination
of the Austrian Stroke Unit Registry found that air
transport was associated with greater thrombolysis
activity compared to a standard ambulance (OR
3.36; 95% CI 2.8–4.0) and physician ambulance
(OR 1.45; 95% CI 1.2–1.7), and a mean 30 min
(95% CI 41–18) less onset to hospital arrival time
compared to standard ambulance but not physician
ambulance (5 min longer; 95% CI 1–9) [43]. How-
ever, there was no information regarding air trans-
port availability or the criteria used to trigger its
dispatch in preference to ground transport when it
was available.
Recommendation
Air medical transport is not suggested outside of set-
tings where a pragmatic decision has been taken that
geographical conditions favour air transport.
(weak; very low quality of evidence)
PICO 14. In acute stroke patients do pre-hospital neu-
roprotective therapies improve outcome?
Three RCTs of neuroprotective therapies initiated
before hospital admission were identiﬁed.
The ﬁrst study was a randomized, controlled, dou-
ble blind, placebo controlled study of oral nimodipine
30 mg every 6 h for 10 days in patients in whom
treatment could be initiated within 6 h of stroke onset
[44]. There was no signiﬁcant diﬀerence between the
nimodipine group and the placebo group on the pri-
mary outcome, which was deﬁned as death or depen-
dency at 3 months.
The second study was a randomized, placebo con-
trolled double blind study of intravenous infusion of
magnesium sulfate started in the ambulance in both
ischaemic and haemorrhagic stroke [45]. The study
included all stroke patients in whom treatment could
be initiated up to 2 h after symptom onset. Active
treatment did not decrease the risk of being dead or
dependent 90 days after the stroke.
The third study was a placebo controlled, open label
study of remote ischaemic preconditioning for ischaemic
stroke [46]. The primary end-point was penumbral sal-
vage, deﬁned as the volume of the perfusion–diﬀusion
mismatch not progressing to infarction after 1 month.
The trial failed to show a diﬀerence between patients
receiving remote ischaemic preconditioning and not.
Recommendation
The use of any neuroprotective intervention in persons
with suspected acute stroke was not recommended in
the pre-hospital setting.
(strong; high quality of evidence)
Discussion
A serious limitation of this guideline is the paucity of
RCTs available on pre-hospital management of
stroke. The GRADE system only allows grading of
the strength of recommendation as strong or weak.
This on the one hand allows a clear statement on a
speciﬁc PICO question, but on the other hand does
not allow an intermediate recommendation in cases
assumed to have insuﬃcient data. For a number of
PICO questions no recommendation could be given
because of insuﬃcient data. Based on consensus a
strong recommendation was given for some PICO
questions for which no RCTs were available, e.g.
when observational studies consistently showed a simi-
lar eﬀect, or if the panel found that desirable conse-
quences outweigh undesirable consequences, or if
most or all patients would be best served by a particu-
lar management strategy.
Despite low quality of evidence public educational
campaigns to increase public awareness of immedi-
ately calling EMS for persons with suspected acute
stroke is strongly supported. Studies were very hetero-
geneous, and the potential clinical beneﬁt of public
campaigns may be diﬃcult to identify in a short-term
follow-up. Further studies are required to ﬁnd out
which methods are most eﬀective in successfully edu-
cating the general public about the urgency of stroke.
Moderate quality of evidence was found to strongly
support the training of EMS personnel in recognizing
the symptoms of stroke using simple stroke scales,
such as the FAST or LAPSS. No recommendation
can be given for a speciﬁc stroke scale.
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Moderate quality of evidence was found to strongly
support implementing a pre-hospital ‘code stroke’ sys-
tem by the EMS, which includes highest priority
ambulance dispatch, prioritized transport to the clos-
est ‘stroke-ready’ centre and pre-notiﬁcation of the
receiving hospital. When possible, EMS should bypass
hospitals that are not ready to deliver appropriate
acute stroke treatment immediately. Pre-notiﬁcation
allows the stroke team to get ready before the patient
actually arrives at the hospital.
Further studies are required to investigate whether
pre-hospital stroke scales predicting large vessel occlu-
sion might be used as a triaging tool to select stroke
patients for direct transport to comprehensive stroke
centres capable of endovascular interventions.
Very low quality of evidence is available for pre-
hospital management of physiological parameters,
such as treatment of hypoxia, management of blood
pressure and hyperthermia. Nevertheless, maintaining
normoxia is strongly recommended, and the use of
blood pressure lowering medication and of insulin in
persons with suspected stroke and hyperglycaemia is
not recommended unless in cases of extreme urgency.
Preliminary studies using bidirectional audiovisual
telemedicine during ambulance transport show that
this method is feasible and may provide valuable
information to the hospital stroke team. However,
such intervention should not cause any delay in the
pre-hospital stroke care pathways, and its additional
value on top of existing pre-hospital ‘code stroke’ sys-
tems, including systematic pre-notiﬁcation of the
receiving hospital, will have to be supported by RCTs.
Despite recent studies reporting the feasibility of
mobile emergency stroke units in delivering intra-
venous thrombolysis at the scene, there is currently no
evidence that this costly intervention improves out-
come. Mobile stroke units allowing CT angiography
could be useful for the early identiﬁcation of patients
with large artery occlusion.
No evidence was found for the pre-hospital use of
laboratory biomarkers in diagnosing stroke, POC lab-
oratory analysis for blood count and INR, and neuro-
protective therapies.
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